A 76-year-old woman with erratic anticoagulation

Cleveland Clinic Journal of Medicine

Volumn 71, Issue 8, 2004, Pages 651-656

  Lesho, Emil P ^a,d   Saullo, Louise ^b   Udvari Nagy, Szilvia ^c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Greater Hazleton Health Alliance   (United States)

^c DEPARTMENT OF COLORECTAL SURGERY   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINOTRANSFERASE; AMIODARONE; CIMETIDINE; CIPROFLOXACIN; CLARITHROMYCIN; CLOFIBRATE; CYCLOOXYGENASE 2 INHIBITOR; ERYTHROMYCIN; FLUCONAZOLE; FLUINDOSTATIN; FLUVOXAMINE; GEMFIBROZIL; GINGER EXTRACT; HERBACEOUS AGENT; HYDROCHLOROTHIAZIDE; HYPERICUM PERFORATUM EXTRACT; ISONIAZID; ITRACONAZOLE; KETOCONAZOLE; METRONIDAZOLE; MEVINOLIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROPAFENONE; SIMVASTATIN; TAMOXIFEN; UNINDEXED DRUG; VITAMIN K GROUP; WARFARIN;

AGED; ALBUMIN BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ANTICOAGULATION; BLEEDING; BLOOD CLOTTING DISORDER; CASE REPORT; DIAGNOSTIC TEST; DRUG METABOLISM; DRUG USE; DRUG WITHDRAWAL; FEMALE; GINGIVA BLEEDING; HEMATURIA; HUMAN; INTERNATIONAL STANDARD UNIT; PROTHROMBIN TIME; REVIEW; SIDE EFFECT;

EID: 4444273203     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.71.8.651     Document Type: Review

References (33)

1. Bermas BL, Schur PH. Clinical manifestations and diagnosis of the antiphospholipid antibody syndrome. In: Rose BD, editor. Up-To-Date. Wellesley, MA: Up-To-Date, 2003.
2. Drews RE. Approach to the patient with a bleeding diathesis. In: Rose BD, editor. Up-To-Date. Wellesley, MA: Up-To-Date, 2003.
3. Zehnder JL. Clinical use of coagulation tests. In: Rose BD, editor. Up-To-Date. Wellesley, MA: Up-To-Date, 2003.
4. The Stroke Prevention in Atrial Fibrillation Investigators. Bleeding during antithrombotic therapy in patients with atrial fibrillation. Arch Intern Med 1996; 156:409-416.
5. Hylek EM, Skates SJ, Sheehan MA, et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with non-rheumatic atrial fibrillation. N Engl J Med 1996; 335:540-546.
6. The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995; 333:5-10.
7. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial. Lancet 1996; 348:633-638.
8. Levine MN, Raskob G, Hirsh J. Hemorrhagic complications of long-term anticoagulant therapy. Chest 1989; 95:26s-36s.
9. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998; 105:91-99.
10. Routledge PA, Chapman PH, Davies DM, et al. Factors affecting warfarin requirements. Eur J Clin Pharmacol 1979; 15:319-322.
11. Routledge PA, Chapman PH, Davies DM, Rawlins MD. Pharmacokinetics and pharmacodynamics of warfarin at steady state. Br J Clin Pharmacol 1979; 8:243-247.
12. Brater DC. Warfarin drug interactions. In: Rose BD, editor. Up-To-Date. Wellesley, MA: Up-To-Date, 2003.
13. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343:687-691.
14. Coon WW, Willis PW III. Hemorrhagic complication of anticoagulant therapy. Arch Intern Med 1974; 133:386-392.
15. Wintzen AR, de Jonge H, Loeliger EA, et al. The risk of intracerebral hemorrhage during oral anticoagulation treatment: a population study. Ann Neurol 1984; 16:553-558.
16. Pengo V, Legnani C, Noventa F, Palareti G. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A multicenter inception cohort study. ISCAT Study Group. Italian Study on Complications of Oral Anticoagulant Therapy. Thromb Heamost 2001; 85:418-422.
17. Wells PS, Forgie MA, Simms M, et al. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism. Arch Intern Med 2003; 163:917-920.
18. Brass LM, Krumholz HM, Scinto JD, Mathur D, Radford M. Warfarin use following ischemic stroke among Medicare patients with atrial fibrillation. Arch Intern Med 1998; 158:2093-2100.
19. Hart GH. Intensity of anticoagulation to prevent stroke in patients with atrial fibrillation [letter]. Ann Intern Med 1998; 128:408.
20. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998; 279:657-662.
21. Sabin JE, Daniels N. Acetaminophen and warfarin. Undesirable synergy. JAMA 1998; 279:702-703.
22. Ernst E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med 2002; 136:42-53.
23. Palareti G, Hirsh J, Legnani C, et al. Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. Arch Intern Med 2000; 160:470-478.
24. Torpy JM. Integrating complementary therapy into care. JAMA 2002; 287:306-308.
25. Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother 2000; 34:1478-1482.
26. Koo KL, Ammit AJ, Tran VH, Duke CC, Roufogalis BD. Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation. Thromb Res 2001; 103:387-397.
27. Verma SK, Bordia A. Ginger, fat and fibrinolysis. Indian J Med Sci 2001; 55:83-86.
28. Pribitkin ED, Boger G. Herbal therapy: what every facial plastic surgeon must know. Arch Facial Plast Surg 2001; 3:127-132.
29. Hodges PJ, Kam PCA. The peri-operative implications of herbal medicines. Anaesthesia 2002; 57:889-899.
30. Second report of the Sixty Plus Reinfarction Study Research Group. Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1982; 1:64-68.
31. Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med 2000; 160:1612-1617.
32. Hirsh J, Fuster V. Guide to anticoagulant therapy. Part 2: Oral anticoagulants. Circulation 1994; 89:1469-1480.
33. Crowther MA, Douketis JD, Schnurr T, et al. Oral vitamin K reversed warfarin-associated coagulopathy faster than subcutaneous vitamin K. Ann Intern Med 2002; 137:251-254.